-
Prostaglandin E2: Advanced Protocols & Troubleshooting for I
2026-07-06
Prostaglandin E2 (PGE2) empowers researchers to precisely dissect immune, gastrointestinal, and reproductive pathways through potent, receptor-selective signaling. This guide translates recent reference breakthroughs and peer-validated workflows into actionable lab strategies—optimizing both reproducibility and data quality for inflammation research.
-
TH287 MTH1 Inhibitor: Applied Protocols for Cancer Radiosens
2026-07-05
TH287, a highly potent MTH1 inhibitor, offers a targeted approach to radiosensitizing resistant cancer cells by amplifying oxidative DNA damage. Explore advanced workflows, protocol parameters, and troubleshooting strategies that leverage this compound for selective cancer cell killing with minimal toxicity to healthy tissue.
-
EdU Imaging Kits (Cy5): Precision S-Phase Cell Proliferation
2026-07-04
EdU Imaging Kits (Cy5) empower researchers to quantify S-phase DNA synthesis with high sensitivity and minimal background, outperforming traditional BrdU methods. This article explores optimized workflows, advanced use-cases, and troubleshooting strategies for fluorescence microscopy and flow cytometry using the APExBIO kit.
-
ORAI2/JNK/NFAT1 Axis Drives Early Salivary Gland Fibrosis Po
2026-07-03
This study identifies ORAI2 as a key mediator of early-stage postirradiation fibrosis in salivary glands, acting via a novel ORAI2/JNK/NFAT1/TGF-β1 axis. Pharmacological inhibition of store-operated calcium entry (SOCE) effectively mitigated fibrosis and restored gland function, providing new targets for intervention in radiation-induced gland injury.
-
Peroxidasin Drives Glycolytic Reprogramming in Glioblastoma
2026-07-03
This study identifies peroxidasin (PXDN) as a pivotal regulator of glycolytic metabolism and malignant progression in glioblastoma through LDHA modulation. The findings offer mechanistic insight for potential diagnostic and therapeutic strategies targeting metabolic vulnerabilities in GBM.
-
Dynasore: Practical Guide to Dynamin GTPase Inhibition in En
2026-07-02
Dynasore is a reversible, non-competitive inhibitor of dynamin family GTPases, enabling researchers to acutely block dynamin-mediated endocytosis and vesicle trafficking. This compound is best suited for dissecting membrane trafficking mechanisms or validating the role of dynamin in cellular uptake pathways, but should not be used where off-target effects or long-term dynamin inhibition might confound results.
-
Dissecting Drug Response Metrics in Cancer In Vitro Models
2026-07-02
Schwartz's dissertation advances the evaluation of anticancer drug responses by distinguishing between proliferative arrest and cell death in vitro. This work redefines how researchers interpret efficacy metrics, improving accuracy in preclinical testing and enabling better-informed use of topoisomerase 1 inhibitors like Topotecan HCl.
-
Verbascoside as a PKC/NF-κB Inhibitor: From Synaptic Pruning
2026-07-01
Explore how Verbascoside, a potent PKC/NF-κB inhibitor, enables advanced studies from osteoclastogenesis to neuroinflammatory mechanisms. This article uniquely connects molecular inhibition to practical assay choices, distinguishing APExBIO's Verbascoside from other solutions.
-
Connexin 43/NF-κB Axis in AngII-Induced Macrophage Polarizat
2026-07-01
This study elucidates how angiotensin II (AngII) drives pro-inflammatory M1 macrophage polarization via the connexin 43 (Cx43)/NF-κB pathway in RAW264.7 cells. The findings demonstrate that selective Cx43 hemichannel blockade attenuates this process, highlighting a mechanistic link relevant for cardiovascular and inflammatory disease research.
-
ω-Agatoxin IVA TFA: Elevating Synaptic Transmission Research
2026-06-30
ω-Agatoxin IVA TFA stands out as a selective P/Q-type calcium channel blocker, enabling precise dissection of neuronal signaling and neuroprotection mechanisms. This guide details optimized experimental workflows, troubleshooting strategies, and the transformative impact of Cav2.1 inhibition in contemporary neuroscience.
-
HA Peptide Tags: Strategic Innovation in Translational Resea
2026-06-30
Explore how the Influenza Hemagglutinin (HA) Peptide is redefining experimental precision and workflow efficiency in protein tagging, purification, and exosome pathway studies. This thought-leadership article blends mechanistic detail with actionable strategy for translational researchers, uniquely connecting protein epitope tagging to the frontiers of exosome biology.
-
Lipo3K Transfection Reagent: Enabling Glycolytic Pathway Stu
2026-06-29
Explore how Lipo3K Transfection Reagent empowers high-efficiency nucleic acid delivery for advanced glycolytic metabolism research in glioblastoma models. Discover distinct workflow advantages and actionable protocols for gene expression and RNA interference studies.
-
JNJ-10198409: Precision Platelet-Derived Growth Factor Recep
2026-06-29
JNJ-10198409 delivers nanomolar precision in blocking PDGF-BB signaling, enabling robust antiangiogenic and antiproliferative assays. Its ATP-competitive mechanism streamlines experimental modeling of tumor growth and fibroproliferative disorders, with validated workflows and troubleshooting strategies from APExBIO.
-
LMO2-LDB1 Complex Drives AML Progression: Mechanisms and Imp
2026-06-28
This study elucidates how the interaction between LMO2 and LDB1 promotes acute myeloid leukemia (AML) cell proliferation and survival. By mapping their mechanistic interplay through molecular and functional assays, the research highlights the LMO2/LDB1 complex as a critical oncogenic driver and potential therapeutic target in AML.
-
Lipo3K Transfection Reagent: Advancing Next-Gen Nucleic Acid
2026-06-27
Explore how Lipo3K Transfection Reagent enables high-efficiency nucleic acid delivery for gene expression studies, especially in challenging cell types. This in-depth review uncovers its scientific innovations and practical advantages for complex molecular biology workflows.
485 records 8/33 page Previous Next First page 上5页 678910 下5页 Last page